Patent 8216609 was granted and assigned to Torrent Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office.
A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form.